Internal Medicine Alert
RSSArticles
-
Lixisenatide Injection (Adlyxin)
Lixisenatide is indicated as an adjunct to diet and exercise to improve glycemic control in adults suffering from type 2 diabetes mellitus.
-
Dual Antiplatelet Therapy Appears More Effective Than Single Therapy
It appears short-term dual antiplatelet therapy is superior to prolonged treatment, but a difference in outcome must be confirmed by further well-designed randomized, clinical trials.
-
Greater Weight Loss Later in Life Associated with Increased Risk of Mild Cognitive Impairment
In a population-based, prospective study of subjects ≥ 70 years of age, increasing weight loss per decade from midlife to late-life was associated with an increased risk of incident mild cognitive impairment.
-
Wheat Causes Intestinal Immune Activation in Some Patients Without Celiac Disease
Some patients without celiac disease may exhibit wheat sensitivity with demonstrated intestinal epithelial cell damage.
-
Too Little of a Good Thing Can Be a Bad Thing
A healthy lifestyle may substantially reduce the burden of cancer.
-
Wide Rhythm in a Patient with Chest Pain
-
Clinical Briefs
In this section: A new statin toxicity emerges; debates about diabetes screening continues; and exploring links between chronic fatigue and serious outcomes.
-
Obeticholic Acid Tablets (Ocaliva)
Obeticholic acid provides an FDA-approved treatment option for patients who have not responded adequately to or are unable to tolerate ursodeoxycholic acid.
-
Combination of Simvastatin Plus Vitamin D Offers New Hope for Migraine Prevention
Recent study shows the combination of simvastatin plus vitamin D3 is effective in the prevention of headaches in adults with episodic migraine.
-
Preventing 90% of Stroke with 10 Modifiable Risk Factors
Controlling 10 modifiable risk factors would prevent 90.7% of strokes, according to results from a 32-country study.